My brother told me at Christmas that semaglutide "is just a vanity drug" and that I'm "taking the lazy approach." So I pulled up my labs. This is what I showed him.

He got quiet. Then he said "I didn't know all that was wrong." And that's the point — from the outside, obesity looks cosmetic. But inside, everything was breaking down. Every single metabolic marker was abnormal and now every single one is normal or near-normal.

"Vanity drug." Sure. If vanity means wanting to meet my grandchildren someday.

M/49, 6'0".

Printing this out and laminating it for the next family gathering where someone has opinions about my medication. Every single marker moved from pathological to normal. EVERY. SINGLE. ONE.

The medication reduction alone is a powerful data point. Going from 4 daily medications to 1 is not vanity — it's disease reversal.

As a healthcare provider, I see this stigma constantly and it's genuinely harmful. It prevents people from seeking treatment for a chronic disease.

Obesity is a neuroendocrine disorder with strong genetic determinants. We don't call insulin "the lazy approach" to type 1 diabetes. We don't call antidepressants "the easy way out" of depression. The double standard applied to obesity medications reflects deep societal bias, not medical reality.

Your labs tell an unambiguous story of metabolic rescue. That ALT going from 62 to 28 suggests your liver was developing steatohepatitis. Untreated, that can progress to cirrhosis. The A1C of 8.4 means you were at high risk for diabetic retinopathy, neuropathy, and nephropathy. These are not cosmetic concerns — they're sight, sensation, and organ function.

I'm glad your brother listened. Most do, when confronted with actual data.

The "4 meds to 1 med" line is what gets me. Each of those medications was treating a separate consequence of the same underlying disease. Instead of putting out four small fires, you put out the one big fire that was causing all of them.

I want to highlight something specific from your table:

HDL: 32 → 48

An HDL of 32 in a man is a strong independent risk factor for cardiovascular disease — it's below the 10th percentile. Every 1 mg/dL increase in HDL is associated with roughly a 2-3% decrease in cardiovascular risk. Your 16-point increase represents an estimated 32-48% risk reduction from HDL improvement ALONE, before considering the triglyceride, LDL, blood pressure, and inflammatory marker improvements.

When you stack all of these improvements together, the composite cardiovascular risk reduction is profound. Your 10-year ASCVD risk score probably dropped by 50% or more.